Toronto, Ontario--(Newsfile Corp. - February 17, 2017) - BFK Capital Corp. (TSXV: BFK.P) ("BFK" or the "Company"),
a Capital Pool Company, is pleased to announce that the Company has been granted an extension by the TSX Venture Exchange
("TSXV") to complete its Qualifying Transaction ("QT") before August 23, 2017. The Company is required to complete a
QT with this requirement being satisfied by the TSXV issuing a final bulletin that evidences the TSXV's final acceptance and the
closing of the QT. However, if this requirement is not met by August 23, 2017, then the Company's shares will be transferred to
NEX.
Regarding the Company's trading status, reinstatement to trading can occur either when the Company completes its QT in
accordance with TSXV Policy 2.4 or upon application for reinstatement satisfactory to the Exchange at the time of transfer to
NEX.
The Company would also like to announce that at the annual and special meeting of its shareholders held on January 25, 2017, the
Company received all of the requisite shareholder approvals necessary to complete its QT with The Hydropothecary Corporation
("THC") (the "Transaction"). The Company continues to work with the TSXV and THC to obtain conditional approval of
the Transaction. Details on the Transaction with THC can be found in the Company's press release dated November 17, 2016.
Forward-Looking Information
This press release contains forward-looking information based on current expectations. Statements about the closing of the
Transaction and the parties' ability to satisfy closing conditions and receive necessary approvals are all forward-looking
information. These statements should not be read as guarantees of future performance or results. Such statements involve known and
unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially
different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there
can be no assurance that the Transaction will occur or that, if the Transaction does occur, it will be completed on the terms
described above. BFK and THC assume no responsibility to update or revise forward-looking information to reflect new events or
circumstances unless required by law.
Cautionary Statements
Completion of the transaction is subject to a number of conditions, including but not limited to, TSXV
acceptance and if applicable pursuant to TSXV requirements, majority of the minority shareholder approval.
Where applicable, the transaction cannot close until the required shareholder approval is obtained. There can be no assurance that
the transaction will be completed as proposed or at all.
Investors are cautioned that, except as disclosed in the management information circular or filing statement to be prepared
in connection with the transaction, any information released or received with respect to the transaction may not be accurate or
complete and should not be relied upon. Trading in the securities of a capital pool company should be considered highly
speculative.
The TSXV has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the
contents of this press release.
Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of
the TSXV) accepts responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Riccardo Forno
CEO
BFK Capital Corp.
(416) 361-2817
Sebastien St-Louis
President and CEO
The Hydropothecary Corporation
(613) 293-4515
